← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #934 OF 1,000 MOST-CITED

Time to report - 10 days

FDA cited this observation 15 times across 14 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Devices15
BY FISCAL YEAR
FY20252
FY20241
FY20234
FY20222
FY20192
FY20182
FY20172

How FDA worded it — real examples

A report of the required information regarding device correction and removal actions was not sent to FDA within 10 days of initiating the correction or removal.

Silex Medical, LLC · Southington, Connecticut · Devices · 2025-04-23

A report of the required information regarding device correction and removal actions was not sent to FDA within 10 days of initiating the correction or removal.

Noah Medical Corporation · San Jose, California · Devices · 2024-11-26

A report of the required information regarding device correction and removal actions was not sent to FDA within 10 days of initiating the correction or removal.

Dr Franz Koehler Chemie Gmbh · Bensheim · Devices · 2024-04-11

A report of the required information regarding device correction and removal actions was not sent to FDA within 10 days of initiating the correction or removal.

Medtronic Neuromodulation · Minneapolis, Minnesota · Devices · 2023-05-05

A report of the required information regarding device correction and removal actions was not sent to FDA within 10 days of initiating the correction or removal.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. · Best · Devices · 2023-01-26

A report of the required information regarding device correction and removal actions was not sent to FDA within 10 days of initiating the correction or removal.

Compass Health Brands (Corporate Office) · Middleburg Heights, Ohio · Devices · 2022-12-19

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Medical devices

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →